- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07647796
Infection Prevention for "Bellwether" Surgery in Ethiopia
9. juni 2026 opdateret af: Helen Sinabulya, Karolinska Institutet
Infection Prevention for "Bellwether" Surgery in Ethiopia: Efficacy, Antimicrobial Resistance, Long-term Patient Outcomes, and Cost-effectiveness
The study examines surgical site infections and antimicrobial resistance following life-saving surgeries like C-sections and leg fracture repairs in Ethiopia.
It does not include healthy volunteers because it specifically focuses on patients who require these urgent operations due to medical necessity.
Eligible participants are those undergoing these specific procedures at Tikur Anbessa Specialized Hospital or other participating public hospitals.
While the birth-related portion is for females, the trauma portion includes both men and women, generally of reproductive or working age with no upper age limit.
People are excluded if they are having elective surgeries, cannot provide consent, or cannot be reached for the two-year follow-up period.
The researchers use a mixed intervention based on the "Clean Cut" safety bundle, which includes staff training, surgical checklists, and regular audits.
The main goals are to measure infection rates within 30 days of surgery and track how well patients can function in their daily lives using the WHODAS scale up to 24 months later.
Studieoversigt
Status
Ikke rekrutterer endnu
Intervention / Behandling
Undersøgelsestype
Observationel
Tilmelding (Anslået)
1000
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Helen Sinabulya, Md, PhD
- Telefonnummer: +46705666670
- E-mail: helen.sinabulya@ki.se
Studiesteder
-
-
-
Addis Ababa, Etiopien
- Tikkur Anbessa
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Prøveudtagningsmetode
Ikke-sandsynlighedsprøve
Studiebefolkning
The study population comprises Ethiopian patients requiring emergency "Bellwether" surgeries at Tikur Anbessa Specialized Hospital and participating public facilities.
Specifically, the cohort includes women undergoing Caesarean sections and individuals of both sexes presenting with open tibia or femur fractures.
The population represents adult clinical cases requiring urgent surgical intervention, excluding healthy volunteers and elective procedures.
Beskrivelse
Inclusion Criteria:
- Emergency Caesarean section.
- Open tibia/femur fractures.
- Treated at participating Ethiopian hospitals.
Exclusion Criteria:
- Elective or non-bellwether surgeries.
- Inability to provide informed consent.
- Lost to follow-up for 24-month assessment.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
Lower Limb Fractures
|
This intervention is a multi-modal infection prevention and control (IPC) bundle adapted from the Clean Cut program specifically for emergency "Bellwether" surgeries, including Caesarean sections and open limb fractures, within the Ethiopian public health system.
The bundle incorporates routine sterilization audits and the establishment of structured feedback loops to improve perioperative routines and ensure high adherence to hygiene protocols.
Furthermore, this intervention is specifically evaluated for its impact on both short-term infection rates and long-term functional recovery, integrating clinical outcomes with antimicrobial resistance (AMR) surveillance.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Incidence of Surgical Site Infection (SSI)
Tidsramme: Up to 30 days post-surgery
|
The rate of surgical site infections diagnosed post-operatively.
|
Up to 30 days post-surgery
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Long-term Functional Health Status Assessed by the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)
Tidsramme: Up to 24 months post-surgery
|
Functional health status and disability will be measured using the unabbreviated World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0).
The WHODAS 2.0 yields a total quantitative score ranging from a minimum of 0 to a maximum of 100.
A score of 0 represents no disability (a better outcome), while a score of 100 represents full disability (a worse outcome).
|
Up to 24 months post-surgery
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. september 2026
Primær færdiggørelse (Anslået)
1. august 2030
Studieafslutning (Anslået)
1. august 2030
Datoer for studieregistrering
Først indsendt
12. maj 2026
Først indsendt, der opfyldte QC-kriterier
9. juni 2026
Først opslået (Faktiske)
15. juni 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
15. juni 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
9. juni 2026
Sidst verificeret
1. juni 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- AMR Ethiopia
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-planbeskrivelse
De-identified individual participant data underlying the primary and secondary outcomes, specifically clinical diagnosis of surgical site infections, microbiological antimicrobial resistance profiles, and long-term functional recovery scores using WHODAS 2.0, will be shared.
This includes relevant demographic variables, such as age and sex, to facilitate further meta-analyses while ensuring participant anonymity.
Data related to hospital-level implementation and cost-effectiveness metrics will also be made available to qualified researchers upon reasonable request.
IPD-delingstidsramme
From the start of data collection and until the results are published.
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Brud på underekstremiteterne
-
JHM BioPharma (Tonghua) Co. , Ltd.Ikke rekrutterer endnu
-
InQpharm GroupAfsluttetBlodtryk | Low Density Lipoprotein KolesterolniveauTyskland
-
National Taiwan University HospitalBuddhist Tzu Chi General Hospital; Taipei Medical University Hospital; E-DA... og andre samarbejdspartnereUkendtKoloskopi | Udrensning af tyktarm | Low-Reside diætTaiwan
-
Otsuka Pharmaceutical Co., Ltd.AfsluttetHyper-low-density Lipoprotein (LDL) KolesterolæmiJapan
-
Tyra Biosciences, IncRekrutteringLow Grade Upper Tract Urothelial CarcinomaForenede Stater
-
Otsuka Pharmaceutical Co., Ltd.AfsluttetHyper-low-density Lipoprotein (LDL) KolesterolæmiJapan
-
Jordan Collaborating Cardiology GroupThe Cardiovascular Academy Group of the JCS; The Jordan Cardiac Society... og andre samarbejdspartnereAfsluttetAterosklerotisk kardiovaskulær risiko | Low-density-lipoprotein (LDL) kolesterolJordan
-
Seoul National University HospitalRekrutteringLARS - Low Anterior Resection SyndromeKorea, Republikken
-
Ankara UniversityAarhus University Hospital; Dokuz Eylul University; Lokman Hekim ÜniversitesiAfsluttetLARS - Low Anterior Resection Syndrome
-
Cooperative International Neuromuscular Research...Carolinas Medical Center lead study siteAfsluttetBeckers muskeldystrofi | Limb-Girdle Muskeldystrofi, Type 2A (Calpain-3-mangel) | Limb-Girdle Muskeldystrofi, Type 2B (Miyoshi Myopati, Dysferlin-mangel) | Limb-Girdle Muskeldystrofi, Type 2I (FKRP-mangel)Forenede Stater